Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Serous Adenocarcinoma 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Transcriptome × Clear all
NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

GOG Foundation

Completed
360 enrolled
Gynecologic

Endometrial Serous Adenocarcinoma

NCT03409692 2023-06-29

MMpredict

University of Turin, Italy

Completed
278 enrolled
Plasma cell

Multiple Myeloma

NCT05318391 2022-04-08

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Shanghai Zhongshan Hospital

Completed
324 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡